ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
MHRA authorises Diurnal’s CAH therapy Efmody pharmatimes
July 02, 2021Speciality pharma company Diurnal announced today that the UK Medicines and Healthcare products Regulatory Agency (MHRA) has granted Efmody a marketing authorisation in Great Britain. -
EC authorises Diurnal’s Efmody for CAH pharmatimes
June 02, 2021The European Commission (EC) has approved UK-headquartered pharma company Diurnal’s Efmody for the treatment of congenital adrenal hyperplasia (CAH). -
Five new meds recommended in March CHMP decisions pharmatimes
March 30, 2021The European Medicines Agency’s (EMA) human medicines committee (CHMP) has recommended five new medicines for approval at its March meeting, as well as six recommendations of current indications.
Pharma Sources Insight January 2025
